AMZN
Amazon.com, Inc.
AMZN has the edge over BIRK overall, supported by stronger valuation and lower modeled downside.
BIRK
Birkenstock Holding plc
BIRK offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
BIRK Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Stable |
BIRK's revenue and profitability are currently healthy, and its cash flow and balance sheet are stable.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over BIRK in the historical PE scenario, which offers more potential upside but is not a forecast.
BIRK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 17x | $34.66 | -2.9% |
| Current | 17x | $35.70 | — |
| Fair | 32x | $64.55 | +81% |
| Expensive | 96x | $195 | +447% |
Historical ranges are pointers, not guarantees.
BIRK's PE is 17x, but its earnings don't support one, so it isn't a reliable read right now.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
AMZN has the edge over BIRK on the outlook, with more favorable profitability expectations.
BIRK Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for BIRK, with profitability holding steady.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN's earnings per share have climbed steadily: $12.37 over the past year, up 75% from the year before, and higher year over year for 14 quarters in a row. Its recent earnings include one-off gains.
BIRK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $2.04 | +12% |
| Q1 2026 | $2.13 | +42% |
| Q4 2025 | $2.26 | +74% |
| Q3 2025 | $2.08 | +84% |
| Q2 2025 | $1.82 | +176% |
| Q1 2025 | $1.50 | +154% |
| Q4 2024 | $1.30 | +177% |
| Q3 2024 | $1.13 | +146% |
BIRK has the edge over AMZN on earnings, with stronger typical year-over-year growth.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN's revenue has grown year over year every quarter since late 2020: $202B last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN's operating margin was 14% last quarter, up 4.2 points from the same quarter a year ago, near the top of its range since 2019.
BIRK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $812.6M | +15% |
| Q1 2026 | $698.2M | +9.4% |
| Q4 2025 | $446.5M | +11% |
| Q3 2025 | $584.7M | +15% |
| Q2 2025 | $705.5M | +12% |
| Q1 2025 | $638M | +19% |
| Q4 2024 | $401.8M | +19% |
| Q3 2024 | $506.3M | +22% |
BIRK has the edge over AMZN on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 29% | -2.4 points |
| Q1 2026 | 26% | -4.3 points |
| Q4 2025 | 19% | +1.8 points |
| Q3 2025 | 21% | -0.1 points |
| Q2 2025 | 31% | +3.6 points |
| Q1 2025 | 31% | +3 points |
| Q4 2024 | 18% | +6 points |
| Q3 2024 | 21% | +15 points |
BIRK has the edge over AMZN on profitability, with a higher operating margin.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
BIRK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $224M | -16% |
| Q1 2026 | $2.2M | +$43.5M |
| Q4 2025 | -$72.7M | -$43.4M |
| Q3 2025 | $145.5M | +3.4% |
| Q2 2025 | $266.7M | -10% |
| Q1 2025 | -$41.3M | -212% |
| Q4 2024 | -$29.2M | +$41.4M |
| Q3 2024 | $140.8M | +32% |
BIRK has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
BIRK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.3% | -2.4M shares |
| 1 year | -2.7% | -5M shares |
| 3 years | -0.7% | -1.2M shares |
BIRK has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $260.5M |
| Q1 2026 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN has the edge over BIRK on leverage, with a lower net debt burden relative to earnings.
BIRK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 1.8x | Healthy |
| Q1 2026 | 1.8x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 1.2x | Healthy |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | 1.6x | Healthy |
| Q4 2024 | 1.6x | Healthy |
| Q3 2024 | 1.6x | Healthy |
BIRK's net debt is about 1.8 years of its operating earnings (EBITDA), up from 1.4 years a year ago.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
BIRK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.6 | Neutral |
| Stochastic | 39.8 | Neutral |
BIRK's weekly RSI is 48 (neutral) and its Stochastic is 40 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
BIRK PE vs Consumer Cyclical Sector
| Metric | BIRK | Sector median | Relative |
|---|---|---|---|
| PE | 17x | 18x | 3.1% below |
| PE % | 20 | 29 | 9 pts below |
BIRK has the edge over AMZN on valuation relative to its sector.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has stronger trend alignment. AMZN is above 5 of 5 weekly averages versus BIRK above 1 of 4.
BIRK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $34.2 | 4.4% above |
| 20 week MA | $36.7 | 2.6% below |
| 50 week MA | $38.8 | 8.1% below |
| 100 week MA | $44.3 | 19% below |
BIRK has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 19% below its 100-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over BIRK on returns for 2026, with the stronger performance.
BIRK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2023 | $36.4 | $48.7 | +34% |
| 2024 | $48.7 | $59.1 | +21% |
| 2025 | $59.1 | $42.4 | -28% |
| 2026 YTD | $42.4 | $35.7 | -16% |
BIRK has finished higher in two of the last three years. It's down 16% so far in 2026.